studi
report
simultan
administr
live
ndv
ampv
subtyp
b
vaccin
alongsid
two
live
ibv
vaccin
dayold
maternalantibodi
posit
commerci
broiler
chick
first
experi
chick
divid
four
group
one
unvaccin
three
group
vaccin
live
ndv
vggaavinew
live
vggaavinew
second
experi
live
ampv
subtyp
b
vaccin
use
place
ndv
clinic
sign
monitor
daili
oropharyng
swab
taken
regular
interv
vaccin
viru
detect
blood
collect
dpv
serolog
chick
group
challeng
virul
strain
qx
ampv
subtyp
b
ibv
day
post
challeng
dpc
tracheal
ciliari
protect
assess
ampv
clinic
score
record
dpc
ndv
haemagglutin
inhibit
hi
antibodi
titr
assay
indic
protect
immun
experi
ciliari
protect
ibv
vaccin
group
maintain
protect
virul
ampv
challeng
compromis
ampv
coadminist
ndv
hi
mean
titr
singl
combin
ndvvaccin
group
remain
protect
titr
log
experi
demonstr
simultan
administr
live
ndv
vggaavinew
ampv
subtyp
b
alongsid
vaccin
interfer
protect
confer
ndv
ibv
ampv
newcastl
diseas
nd
caus
avian
paramyxoviru
serotyp
design
orthoavulaviru
infecti
bronchiti
ib
caus
avian
coronaviru
known
give
rise
sever
diseas
chicken
disastr
econom
loss
welfar
concern
nd
ib
import
common
chicken
diseas
worldwid
sinc
respect
last
three
decad
public
laboratori
highlight
import
ampv
caus
drop
egg
product
qualiti
swollen
head
syndrom
chicken
infecti
bronchiti
viru
ibv
avian
metapneumoviru
ampv
newcastl
diseas
viru
ndv
respiratori
rna
virus
primarili
infect
tracheal
epithelium
chicken
number
countri
introduc
use
live
inactiv
ndv
ibv
ampv
vaccin
simultan
vaccin
multipl
live
viral
vaccin
carri
poultri
number
reason
includ
avoid
induc
stress
chick
excess
handl
reduc
vaccin
cost
tradit
ndv
singl
ibv
massachusett
live
vaccin
given
dayold
chick
hatcheri
farm
mostli
spray
howev
diseas
loss
caus
variant
ibv
increas
grow
number
produc
includ
vaccin
dayold
vaccin
programm
three
diseas
ibv
ampv
ndv
routin
control
poultri
industri
use
live
attenu
vaccin
long
last
antibodi
titr
record
inactiv
ndv
vaccin
report
sinc
describ
ibv
vaccin
impair
efficaci
ndv
vaccin
potenti
lead
product
loss
gelb
vaccin
broiler
chicken
introduct
ampv
possibl
heterolog
covaccin
ndv
ampv
ibv
ampv
dayold
investig
public
show
simultan
administr
ampv
vaccin
alongsid
ndv
ibv
vaccin
compat
protect
virul
ibv
ndv
ampv
remain
uncompromis
howev
studi
singl
vaccin
strain
ibv
massachusett
use
emerg
variant
ibv
inclus
variant
ibv
alongsid
massachusett
dayold
vaccin
becom
common
practic
recent
work
shown
ibv
vaccin
undergo
genet
mutat
follow
inocul
chicken
host
persist
mutat
alter
strain
characterist
prefer
monitor
potenti
chang
furthermor
benefici
establish
simultan
vaccin
administr
role
nucleotid
mutat
occur
ibv
gene
subsequ
amino
acid
chang
contrast
ibv
vaccin
strain
prolong
persist
genet
mutat
ndv
ampv
vaccin
strain
report
chicken
date
impact
coadministr
live
ndv
ampv
alongsid
classic
variant
live
ibv
vaccin
ibvampvndv
matern
antibodi
posit
bird
investig
increas
use
covaccin
strategi
commerci
broiler
chick
import
understand
vaccinecombin
may
impact
protect
ibv
ampv
ndv
challeng
studi
report
result
two
experi
live
ibv
vaccin
massachusett
coadminist
alongsid
live
ampv
subtyp
b
live
newcastl
diseas
vaccin
commerci
broiler
chick
chick
dayold
commerci
broiler
chick
obtain
commerci
hatcheri
rais
univers
liverpool
isol
facil
chick
rear
deep
litter
water
feed
provid
ad
libitum
infe
inwat
antibiot
use
throughout
studi
experiment
procedur
conduct
accord
uk
legisl
use
anim
experi
grant
ethic
approv
univers
liverpool
ethic
committe
vaccin
strain
commerci
avail
live
ibv
mass
type
strain
bioral
boehring
ingelheim
lyon
franc
ibv
variant
type
strain
gallivac
boehring
ingelheim
lyon
franc
ndv
vggaavinew
strain
avinew
neo
boehring
ingelheim
lyon
franc
ampv
subtyp
b
nemovac
boehring
ingelheim
lyon
franc
vaccin
administ
studi
vaccin
prepar
prior
administr
use
steril
distil
water
allow
ml
vaccin
per
chick
administ
accord
manufactur
instruct
challeng
strain
virul
viru
strain
ibv
ciliostat
dose
cd
ml
qx
cd
ml
ampv
subtyp
b
cd
ml
use
challeng
challeng
strain
propag
laboratori
use
sever
previou
studi
pcr
bacteri
cultur
confirm
absenc
ndv
ampv
avian
influenza
viru
aiv
infecti
laryngotrach
viru
iltv
infecti
bursal
diseas
viru
ibdv
fowl
adenoviru
fadv
mycoplasma
inocula
experi
chick
randomli
divid
four
group
chick
per
group
kept
separ
isol
unit
dayold
chick
inocul
via
oculo
ml
nasal
ml
rout
follow
vggaavinew
group
mass
group
b
vggaavinew
mass
group
c
steril
h
group
chick
observ
daili
clinic
sign
mild
cough
head
shake
depress
short
durat
sever
gasp
cough
depress
accompani
ruffl
feather
mortal
rate
lesion
follow
necropsi
record
dpv
chick
group
separ
two
group
chick
per
subgroup
chick
challeng
ml
virul
chick
challeng
ml
virul
qx
via
oculonas
rout
chick
observ
daili
clinic
sign
previous
describ
mortal
rate
post
mortem
lesion
record
dpv
oropharyng
op
swab
collect
five
chick
group
dpv
five
trachea
kidney
sampl
collect
group
dpc
five
trachea
kidney
sampl
collect
process
previous
describ
blood
collect
ten
chick
dpv
eight
chick
dpv
detect
ibv
ndv
antibodi
experi
dayold
broiler
chick
randomli
divid
four
group
kept
separ
isol
unit
chick
per
group
dayold
chick
inocul
via
oculo
ml
nasal
ml
rout
follow
ampv
subtyp
b
group
mass
group
b
ampv
subtyp
b
mass
group
c
steril
h
group
chick
observ
daili
clinic
sign
describ
day
post
vaccin
dpv
chick
group
ad
split
twelv
group
five
chick
per
group
chick
challeng
ml
virul
chick
group
challeng
ml
virul
ampv
b
via
oculonas
rout
chick
shaminocul
steril
distil
water
bird
observ
daili
clinic
sign
ibv
challeng
group
score
ampv
challeng
group
score
follow
nasal
exud
mild
exud
unilater
excess
exud
bilater
excess
exud
dpv
oropharyng
op
swab
collect
five
chick
group
dpv
five
trachea
kidney
sampl
collect
dpc
five
trachea
kidney
sampl
collect
process
previous
describ
blood
collect
ten
chick
dpv
eight
chick
dpv
detect
ibv
ampv
antibodi
evalu
tracheal
protect
follow
challeng
day
post
challeng
dpc
five
chick
group
human
kill
wing
vein
inject
sodium
pentobarbit
trachea
remov
chick
process
ciliari
percentag
protect
assess
previous
describ
briefli
ring
bird
examin
maximum
possibl
ciliari
score
indic
protect
cilia
beat
mean
ciliari
score
bird
calcul
percentag
protect
group
calcul
measur
antibodi
level
commerci
elisa
kit
ibv
idexx
main
unit
state
ampv
biochek
er
reeuwijk
netherland
use
accord
manufactur
instruct
titr
result
higher
ibv
ampv
indic
posit
protect
titr
haemagluttin
inhibit
hi
utilis
determin
ibv
ndv
protect
statu
previous
describ
ibv
ndv
ampv
detect
rtpcr
swab
pool
dip
singl
sampl
per
group
per
day
steril
bijou
contain
ml
eagl
serumfre
minimum
essenti
medium
glutamin
streptomycin
mgml
penicillin
iuml
store
requir
rna
extract
swab
tissu
sampl
use
phenol
chloroform
method
subject
rtpcr
ibv
ndv
ampv
posit
amplicon
purifi
sent
bidirect
commerci
sanger
sequenc
sourc
bioscienc
nottingham
uk
ibv
ampv
viral
load
trachea
kidney
total
rna
extract
group
five
trachea
kidney
sampl
use
rneasi
plu
mini
kit
qiagen
manchest
uk
quantif
viral
rna
determin
quantit
rtpcr
qrtpcr
ibv
ampv
ibv
qrtpcr
perform
use
qiagen
onestep
rtpcr
kit
ng
total
rna
per
reaction
ampv
assay
perform
use
qiagen
quantitect
rox
master
mix
ng
total
rna
per
reaction
ct
valu
convert
log
rel
equival
unit
reu
viral
rna
use
previous
determin
standard
curv
ibv
ampv
sequenc
analysi
ibv
gene
sequenc
trim
bp
analys
chromaspro
http
technelysiumcomau
blast
search
conduct
confirm
isol
ident
align
carri
use
clustal
w
singl
nucleotid
polymorph
snp
insert
delet
indel
detect
carri
follow
align
sequenc
vaccin
strain
snp
characteris
nonsynonym
ns
led
amino
acid
chang
synonym
led
amino
acid
chang
insert
delet
indel
defin
insert
delet
nucleotid
alter
sequenc
length
ns
ratio
identifi
posit
purifi
select
pressur
group
calcul
per
day
done
use
neigojobori
method
indic
recov
strain
posit
select
pressur
indic
strain
purifi
select
posit
purifi
select
consid
signific
p
translat
amino
acid
variat
also
identifi
variat
result
chang
hydrophob
note
accord
kyte
doolittl
scale
statist
analysi
statist
analysi
conduct
use
oneway
analysi
varianc
anova
follow
turkey
test
examin
differ
pair
mean
differ
consid
signific
p
analysi
carri
use
spss
statist
follow
dayold
vaccin
ibvvaccin
group
mild
respiratori
sign
record
dpv
qx
challeng
group
receiv
ibv
vaccin
mild
sign
throughout
experi
ibvvaccin
group
qxchalleng
show
mild
sign
total
two
day
dpc
ciliostasi
result
show
ibvvaccin
group
high
protect
ibv
challeng
strain
rang
ndv
hi
titr
group
receiv
ndv
vaccin
log
tabl
wherea
group
receiv
ndv
vaccin
singli
combin
ibv
respect
signific
increas
p
titr
seen
group
ndv
vaccin
compar
group
c
combin
vaccin
dpv
sera
assay
ibv
hi
antibodi
ibvvaccin
group
show
increas
hi
log
titr
dpv
compar
dpv
tabl
furthermor
signific
increas
p
titr
group
b
compar
group
c
ibv
antigen
stronger
respons
toward
compar
hi
antigen
ibv
vaccin
group
group
b
group
c
mean
ibv
elisa
antibodi
titr
dayold
indic
presenc
matern
deriv
antibodi
mda
dpv
antibodi
level
declin
detect
titr
group
group
group
b
group
c
group
despit
detect
level
two
group
receiv
ibv
vaccin
b
c
higher
antibodi
titr
compar
ibvunvaccin
group
ibv
rna
detect
sampl
time
point
dpv
group
b
c
absent
ibvunvaccin
group
masstyp
vaccin
detect
dpv
group
b
dpv
group
c
time
vaccin
identifi
subsequ
sampl
ibvvaccin
group
masstyp
identifi
strain
nucleotid
similar
origin
vaccin
rang
wherea
related
vaccin
strain
ndv
detect
time
total
snp
count
remain
low
except
sampl
group
b
c
dpv
contain
greater
total
snp
count
n
tabl
translat
amino
acid
aa
chang
group
b
group
c
chang
sampl
hydrophob
hydrophil
properti
major
chang
masslik
sampl
hydrophil
hydrophob
averag
ns
ratio
strain
mass
strain
indic
mass
genotyp
significantli
purifi
select
pressur
p
indel
present
sequenc
analys
molecular
detect
ibv
ndv
trachea
kidney
tissu
dpv
ibv
vaccin
strain
recov
trachea
kidney
tissu
group
b
dpv
wherea
sampl
day
posit
group
c
tabl
trachea
sampl
ibvposit
dpv
masstyp
strain
recov
kidney
past
dpv
detect
ndv
sampl
sequenc
similar
ibv
vaccin
strain
singl
except
dpv
major
strain
recov
kidney
trachea
ns
ratio
demonstr
major
partial
nucleotid
variat
effect
translat
amino
acid
composit
except
two
strain
group
c
kidney
sampl
dpv
group
averag
five
nonsynonym
chang
per
strain
translat
three
hydrophob
chang
within
recov
strain
ibv
challeng
dpc
ibv
detect
trachea
group
nonvaccin
trachea
kidney
group
ndv
vaccin
tabl
ibv
vaccin
strain
detect
group
mass
vaccin
similar
vaccin
similar
major
variat
led
chang
translat
amino
acid
n
averag
ns
ratio
howev
one
chang
hydrophob
properti
hydrophil
hydrophob
identifi
sampl
identifi
highli
similar
virul
strain
group
trachea
ibv
qx
challeng
dpc
virul
qx
strain
detect
trachea
kidney
group
nonvaccin
nucleotid
similar
virul
strain
howev
tracheal
sampl
ibvposit
group
ndvvaccin
tabl
vaccin
strain
detect
group
similar
mass
similar
minor
nucleotid
variat
caus
amino
acid
chang
n
averag
ns
ratio
result
seven
hydrophob
chang
hydrophil
hydrophob
hydrophob
hydrophil
vaccin
strain
recov
kidney
sampl
group
b
c
major
chang
sampl
nonsynonym
total
amino
acid
chang
six
caus
chang
hydrophob
ibv
vaccin
tracheal
sampl
viral
load
reduc
dpv
dpv
group
b
log
reu
group
c
log
reu
howev
ibv
presenc
significantli
higher
p
dpv
group
group
b
group
c
compar
dpv
fig
dpv
significantli
higher
tracheal
viral
load
ibvvaccin
group
compar
ndv
ibv
vaccin
group
post
challeng
high
viral
load
present
trachea
fig
kidney
sampl
dpv
group
b
ibv
vaccin
c
ndv
ibv
vaccin
increas
dpv
log
reu
log
reu
respect
fig
post
challeng
fig
significantli
lower
viral
load
present
nonibv
vaccin
group
log
reu
log
reu
log
reu
log
reu
compar
ibv
vaccin
group
log
reu
log
reu
log
reu
follow
challeng
viral
load
chang
group
b
ibv
vaccin
virul
qx
strain
detect
greater
level
control
group
group
compar
challeng
control
group
howev
viral
load
ndv
vaccin
group
remain
low
log
reu
follow
challeng
dpv
ibv
vaccin
group
demonstr
mild
clinic
sign
promin
snick
sneez
start
dpv
group
b
mass
group
c
ampv
mass
respect
continu
dpv
group
ampv
vaccin
group
control
show
clinic
sign
group
present
moder
clinic
sign
point
dpc
follow
ibv
challeng
group
ampv
vaccin
control
show
sign
dpc
dpc
respect
mild
sign
group
subsid
dpc
ampv
challeng
greater
clinic
sign
observ
nonvaccin
bird
group
bird
receiv
ibv
vaccin
group
compar
group
receiv
combin
vaccin
group
sign
clear
ampv
challeng
group
dpc
group
receiv
challeng
viru
absent
clinic
sign
ibv
vaccin
group
show
high
protect
challeng
strain
protect
score
combin
group
demonstr
similar
level
protect
percentag
respect
compar
singl
vaccin
group
mean
serum
ampv
antibodi
titr
dpv
indic
presenc
matern
deriv
antibodi
mda
ampv
fig
dpv
antibodi
level
declin
detect
titr
ibv
vaccin
group
group
b
howev
ampv
vaccin
combin
group
remain
posit
titr
respect
dpc
group
show
antibodi
level
detect
limit
follow
ampv
challeng
group
ampv
vaccin
ibv
vaccin
present
higher
titr
respect
compar
group
receiv
combin
ampv
ibv
vaccin
ampv
vaccinatedampv
challeng
group
combin
vaccinatedampv
challeng
group
significantli
higher
p
titr
compar
nonchalleng
sub
group
abl
detect
ibv
ampv
earli
dpv
howev
ibv
identifi
dpv
detect
ampv
beyond
dpv
either
singl
combin
vaccin
group
partial
sequenc
ibv
posit
sampl
demonstr
high
similar
origin
inoculum
ident
rang
group
b
group
c
masstyp
identifi
dpv
either
group
aver
fig
experi
quantif
ibv
viral
load
trachea
kidney
dpv
follow
vaccin
either
group
b
group
c
vggaavinew
data
present
standard
error
margin
sem
signific
test
carri
within
sampl
point
tissu
type
differ
group
p
label
differ
letter
data
present
standard
error
margin
sem
signific
test
carri
group
tissu
type
differ
group
p
label
differ
letter
ns
ratio
averag
masslik
strain
sampl
tabl
two
sampl
greater
averag
snp
count
also
show
increas
amino
acid
chang
sampl
hydrophob
chang
major
n
chang
hydrophil
hydrophob
dpv
ibv
vaccin
strain
recov
group
b
c
sampl
point
except
kidney
dpv
tabl
detect
ibv
high
nucleotid
similar
initi
vaccin
strain
singl
nonsynonym
chang
time
point
group
b
c
tracheal
sampl
group
c
dpv
snp
translat
nine
amino
acid
variat
contain
singl
hydrophob
hydrophil
chang
ampv
vaccin
detect
dpv
tracheal
sampl
kidney
remain
neg
throughout
ibv
challeng
dpc
ibv
detect
kidney
group
ibvvaccin
group
ampv
ibvvaccin
sampl
high
similar
vaccin
strain
tabl
sampl
group
ampv
vaccin
nonvaccin
posit
ibv
ident
challeng
strain
group
receiv
challeng
ibv
neg
ampv
detect
bird
challeng
ampv
subtyp
b
challeng
dpc
ampv
detect
group
ampv
vaccin
group
ampv
ibv
vaccin
viru
detect
trachea
bird
group
ibv
vaccin
trachea
kidney
group
nonvaccin
post
vaccin
ibv
vaccin
tracheal
sampl
viral
load
increas
dpv
dpv
group
b
log
reu
group
c
log
reu
fig
howev
ibv
presenc
significantli
lower
p
dpv
group
b
compar
dpv
ibv
vaccin
group
group
b
significantli
higher
tracheal
viral
load
compar
combin
group
c
vaccin
group
dpv
group
neg
dpv
viral
load
kidney
significantli
higher
dpv
p
group
b
compar
combin
group
c
post
challeng
ibv
group
vaccin
ibv
show
neg
qrtpcr
wherea
group
ampv
vaccin
group
nonvaccin
show
read
log
reu
respect
fig
post
vaccin
kidney
sampl
neg
ibv
group
dpv
howev
viral
load
increas
dpv
ibv
vaccin
group
group
b
log
reu
group
c
log
reu
post
challeng
ibv
group
receiv
ibv
vaccin
show
viru
presenc
group
log
reu
group
log
reu
vaccin
group
low
detect
level
group
log
reu
group
log
reu
covaccin
dayold
broiler
chick
ndv
ampv
alongsid
two
differ
live
ibv
mass
vaccin
impair
protect
confer
either
ibv
ampv
challeng
experi
follow
ibv
challeng
mild
respiratori
sign
observ
first
two
day
none
thereaft
demonstr
clinic
protect
confer
ibv
mass
without
ndv
ampv
ciliostasi
analysi
also
use
confirm
ibv
protect
higher
protect
percentag
suggest
better
protect
virul
ibv
challeng
ciliostasi
result
current
studi
highlight
excel
ibv
protect
qx
challeng
group
receiv
ibv
vaccin
given
along
ampv
ndv
vaccin
previou
work
shown
combin
mass
confer
excel
ciliari
protect
asian
qx
middl
east
ibv
strain
ibv
vaccin
strain
combin
ndv
ampv
vaccin
protect
level
remain
reconfirm
combin
vaccin
compromis
protect
confer
virul
ibv
addit
ciliastop
test
detect
viru
viral
load
trachea
kidney
challeng
group
attempt
demonstr
protect
ibv
qx
vaccin
virus
detect
trachea
dpc
howev
virul
challeng
virus
present
suggest
host
clearanc
ibv
vaccin
least
dpv
coadministr
either
ndv
ampv
alongsid
ibv
vaccin
caus
lower
ibv
vaccin
viru
load
trachea
kidney
dpv
howev
postchalleng
virul
ibv
combin
ibv
ndv
ampv
vaccin
effect
viral
load
compar
ibv
vaccin
alon
experi
despit
rel
higher
tracheal
viral
load
low
reu
valu
shown
kidney
tissu
nonibv
vaccin
group
follow
qx
challeng
result
along
ciliastop
test
demonstr
compar
level
protect
found
ibv
vaccin
strain
given
either
alon
alongsid
ndv
ampv
vaccin
control
newcastl
diseas
paramount
import
endem
countri
control
normal
achiev
use
live
inactiv
vaccin
haemagluttin
inhibit
titr
tradit
use
confirm
protect
ndv
challeng
mean
ndv
hi
titr
singl
combin
vaccin
group
describ
log
protect
titr
virul
ndv
current
work
show
simultan
vaccin
ndv
commerci
broiler
chick
interfer
induct
protect
immun
ndv
studi
follow
challeng
virul
ampv
clinic
sign
found
singl
ampv
combin
ampv
vaccin
group
confirm
clinic
protect
challeng
viru
furthermor
follow
challeng
virul
strain
antigen
detect
rtpcr
tissu
sampl
either
vaccin
group
ampv
elisa
antibodi
titr
triplevaccin
group
lower
singl
vaccin
group
echo
find
previou
work
howev
report
level
humor
antibodi
associ
clinic
protect
ampv
evid
experiment
vaccin
commerci
broiler
ampv
ibv
mda
ampv
subtyp
b
two
ibv
strain
advers
effect
clinic
protect
confer
virul
challeng
experi
persist
vaccin
strain
follow
individu
ibv
ndv
ampv
combin
ndv
ampv
vaccin
monitor
interv
ndv
ampv
classic
rtpcr
appli
rna
extract
oropharyng
swab
detect
ndv
vaccin
sampl
point
previou
work
shown
detect
ndv
vaccin
viru
spf
chicken
four
day
post
vaccin
experi
first
sampl
carri
dpv
failur
detect
ndv
may
due
rapid
clearanc
vaccin
ampv
possibl
detect
viru
dpv
use
dri
oropharyng
swab
dpv
tracheal
tissu
identifi
ampv
vaccin
dpv
combin
ibv
ampv
vaccin
group
differ
singl
combin
vaccin
group
current
studi
suggest
combin
vaccin
impair
host
abil
rapidli
clear
ampv
vaccin
strain
ibv
vaccin
strain
previous
shown
persist
chicken
longer
period
investig
growth
kinet
genet
characterist
live
ibv
vaccin
use
studi
cross
compar
previou
report
vaccin
strain
detect
op
swab
throughout
current
experi
variant
strain
domin
later
age
bird
experi
sanger
sequenc
show
genotyp
strain
recov
use
op
swab
alter
mass
dpv
report
previous
mass
genotyp
made
major
detect
earli
sampl
day
dpv
strain
becam
domin
strain
dpv
reason
shift
genotyp
mass
known
howev
previou
work
highlight
differ
ibv
strain
differenti
induc
host
express
pathway
particular
ifnb
differ
may
play
role
host
abil
clear
mass
vaccin
viru
earlier
time
point
compar
vaccin
work
requir
understand
potenti
underli
mechan
point
nucleotid
similar
recov
mass
vaccin
strain
drop
compar
origin
vaccin
sequenc
suggest
experiment
condit
vaccin
strain
underw
minim
alter
follow
inocul
similarli
vaccin
strain
remain
high
one
sampl
point
except
dpv
experi
limit
genet
chang
note
tissu
sampl
snp
per
sequenc
mass
vaccin
strain
respect
higher
number
polymorph
seen
sequenc
compar
massachusett
indic
persist
particular
genotyp
may
contribut
greater
genet
variat
within
local
viru
popul
howev
ns
ratio
suggest
purifi
select
genotyp
therefor
evolutionari
constraint
previou
work
impli
amino
acid
variat
follow
consist
pattern
time
also
wit
current
studi
persist
alter
wit
tissu
vaccin
program
conclus
studi
indic
combin
vaccin
consist
ndv
vggaavinew
ampv
subtyp
b
alongsid
two
strain
ibv
massachusett
impair
protect
immun
global
import
ibv
ndv
ampv
strain
includ
studi
